ABSCI
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creationâ„¢ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteinsâ„¢ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugsâ„¢. For more information visit www.absci.com.
ABSCI
Industry:
Artificial Intelligence Biopharma Biotechnology Life Science
Founded:
2011-01-01
Address:
Vancouver, Washington, United States
Country:
United States
Website Url:
http://www.absci.com
Total Employee:
101+
Status:
Active
Contact:
360-949-1041
Email Addresses:
[email protected]
Total Funding:
237.86 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Google Apps For Business GoDaddy DNS GoDaddy Google Web Toolkit
Similar Organizations
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-14 | Totient | Totient acquired by Absci | N/A |
| 2021-01-12 | Denovium | Denovium acquired by Absci | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Venture Round - Absci
D1 Capital Partners
D1 Capital Partners investment in Venture Round - Absci
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Absci
aMoon Fund
aMoon Fund investment in Venture Round - Absci
Irving Investors
Irving Investors investment in Venture Round - Absci
Helicase Venture
Helicase Venture investment in Venture Round - Absci
ArrowMark Partners
ArrowMark Partners investment in Venture Round - Absci
Redmile Group
Redmile Group investment in Venture Round - Absci
Casdin Capital
Casdin Capital investment in Venture Round - Absci
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Corporate Round - Absci
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires |
Official Site Inspections
http://www.absci.com Semrush global rank: 4.28 M Semrush visits lastest month: 2.71 K
- Host name: 104.26.6.50
- IP address: 104.26.6.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Absci"
About Us - Absci
Leveraging our synthetic biology roots, Absci has built a proprietary data advantage that fuels a continuous learning cycle: data to train, AI to create, and wet lab to validate in as little as six …See details»
Team - Absci
Dr. Taylor-Weiner leads Absci's AI teams and technology, developing Absci's first-in-class ability to design and validate de novo therapeutic antibodies with zero-shot generative AI. He brings …See details»
Absci - Crunchbase Company Profile & Funding
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our …See details»
Investor Relations | Absci Corp
6 days ago Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creationâ„¢ platform unlocks the potential …See details»
Investor FAQs - Absci Corp
We were formed as AbSci, LLC in August 2011 as a limited liability company under the Oregon Limited Liability Act and subsequently converted into a Delaware limited liability company …See details»
Absci (ABSI) Company Profile & Description - Stock Analysis
Jul 22, 2021 Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development …See details»
Absci Corporation (ABSI) - Yahoo Finance Canada
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies …See details»
Absci Corporation - AnnualReports.com
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. They built their Integrated Drug Creationâ„¢ Platform to identify novel drug targets, discover …See details»
AbSci - Org Chart, Teams, Culture & Jobs - The Org
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. Industries. Biotechnology. Headquarters. …See details»
Absci Company Profile - Office Locations, Competitors, Revenue
Absci has 2 employees across 4 locations and $4.53 m in annual revenue in FY 2024. See insights on Absci including office locations, competitors, revenue, financials, executives, …See details»
Absci and AMD Announce Collaboration and Strategic Investment …
Jan 8, 2025 “Absci’s groundbreaking work in AI drug discovery is a perfect fit for AMD high-performance computing solutions and software, designed for the most demanding AI …See details»
Careers - Absci
At Absci, we innovate with courage, agility, and speed. We experiment and learn quickly from our successes and failures. We go beyond what's expected and push boundaries to inspire others …See details»
Absci: Culture - LinkedIn
Absci | 14,346 followers on LinkedIn. Creating Drugs at the Speed of Ai | Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our …See details»
Absci Corporation (ABSI): history, ownership, mission, how it works ...
[relinking] Home History Owners Mission How It Works How It Makes Money Absci Corporation (ABSI) Information A Brief History of Absci Corporation (ABSI) Company Overview Absci …See details»
Absci Reports Business Updates and First Quarter 2025 Financial …
May 13, 2025 Initiated dosing of participants in the first-in-human study of ABS-101 (anti-TL1A antibody), with interim data expected in the second half of 2025 ABS-201 (anti-PRLR) non …See details»
Contact us - Absci
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.See details»
News releases - Absci Corp
VANCOUVER, Wash. and NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today …See details»
Absci and Owkin Synergize Leading TechBio Platforms to Advance ...
About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated …See details»
ABSI - Absci Corp Latest Stock News & Market Updates
Overview. Absci Corp (ABSI) is a cutting-edge synthetic biology company leveraging generative AI and scalable wet lab technologies to revolutionize the discovery and design of novel …See details»
Partnerships - Absci
This partnership with Absci represents a significant step forward in our journey to bring transformative therapies to patients. By bringing together Owkin’s AI agents that can identify …See details»